Animal model of intrahepatic metastasis of hepatocellular carcinoma: establishment and characteristic

Abstract

One of the most important and striking characteristics of hepatocellular carcinoma (HCC) with intrahepatic metastasis, is that it results in extremely poor prognosis. Animal models have become a fundamental and very useful in research for disease study. However, some limitation has arisen from these model systems. We have therefore established a model of HCC with intrahepatic metastasis and noticed some differential appearances in different HCC cell lines. Luciferase-transfected HCC cell lines MHCC97-H and PLC/PRF/5 were inoculated into SCID mice via spleen. Observation the intrahepatic metastasis by bioluminescence imaging in vivo and comparing of the differential formation of metastatic lesions between different HCC cell lines by incorporating physical anatomy was done. Animal models for HCC intrahepatic metastasis were well established. However, there were some clearly noticed differences between MHCC97-H and PLC/PRF/5 cell lines. The group of MHCC97-H cell line readily metastasis in the liver, whereas group PLC/PRF/5 cell line developed extensive intrahepatic metastasis and formed large tumor in situ in the spleen. MHCC97-H and PLC/PRF/5 cell lines can be used to successfully establish a model of HCC intrahepatic metastasis with distinctive characteristics, which provides an important direction for the study of the mechanism of HCC intrahepatic metastasis, and may hopefully provide a basis for clinical treatment.

Homeobox B5 promotes metastasis and poor prognosis in Hepatocellular Carcinoma, via FGFR4 and CXCL1 upregulation

“…RT-qPCR and western blotting were used to detect the HOXB5 expression in human HCC cell lines with different metastatic potency 29 , 40 - 42 . HOXB5 expression was higher in metastatic HCC cells lines than in HCC cells with low metastatic ability (Figure 1 E).…”

BMI1 Silencing Liposomes Suppress Postradiotherapy Cancer Stemness against Radioresistant Hepatocellular Carcinoma

“…Metastasis mouse model developed from the IR-S and IR-R cell lines in Figure S13. Female BALB/c nude mice (4–6 week, 18–20 g) were injected through mice spleen with 5 × 10 6 IR-S MHCC-97H cells or IR-R MHCC97H cells (200 μL/mouse) to establish the intrahepatic metastasis model. , Subsequently, the mice were given intravenous injection of various solutions for 5 days (200 μL/mouse/day, 30 mg/kg PTC-209) with or without IR-combined therapy. After a 4 week period, the mice were sacrificed, and their livers were harvested for pathological analysis to evaluate tumor metastasis.…”

Angelica Sinensis Polysaccharide-Based Nanoparticles for Liver-Targeted Delivery of Oridonin

“…The results of the H & E staining of the liver sections of tumor-bearing mice in each group are shown in Figure 14. In control group, the liver cells were disordered, the nucleus was abnormally enlarged, and there were different degrees of deformation, which may be related to the invasion and metastasis of liver cancer cells [36,37]. In the free ORI, ASP-DOCA NPs, ORI/ASP-DOCA NPs and ORI/DEX-DOCA NPs groups, the changes in liver cells in tumor-bearing mice were inhibited to varying degrees.…”